Search

Gerald R. Ewoldt

Examiner (ID: 4358, Phone: (571)272-0843 , Office: P/1644 )

Most Active Art Unit
1644
Art Unit(s)
1644
Total Applications
1060
Issued Applications
256
Pending Applications
142
Abandoned Applications
661

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 322425 [patent_doc_number] => 07517657 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-04-14 [patent_title] => 'Peptides for detecting anti-double stranded DNA antibody and uses thereof' [patent_app_type] => utility [patent_app_number] => 11/129260 [patent_app_country] => US [patent_app_date] => 2005-05-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 8 [patent_no_of_words] => 8121 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 85 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/517/07517657.pdf [firstpage_image] =>[orig_patent_app_number] => 11129260 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/129260
Peptides for detecting anti-double stranded DNA antibody and uses thereof May 12, 2005 Issued
Array ( [id] => 6957920 [patent_doc_number] => 20050214290 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-09-29 [patent_title] => 'Methods of blocking tissue destruction by autoreactive T cells' [patent_app_type] => utility [patent_app_number] => 11/128709 [patent_app_country] => US [patent_app_date] => 2005-05-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 12087 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 22 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0214/20050214290.pdf [firstpage_image] =>[orig_patent_app_number] => 11128709 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/128709
Methods of blocking tissue destruction by autoreactive T cells May 12, 2005 Abandoned
Array ( [id] => 7168381 [patent_doc_number] => 20050202014 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-09-15 [patent_title] => 'Methods of blocking tissue destruction by autoreactive T cells' [patent_app_type] => utility [patent_app_number] => 11/129083 [patent_app_country] => US [patent_app_date] => 2005-05-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 12087 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 25 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0202/20050202014.pdf [firstpage_image] =>[orig_patent_app_number] => 11129083 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/129083
Method of treating multiple sclerosis and related t-cell initiated tissue destruction by administering HSA/CD24 May 12, 2005 Issued
Array ( [id] => 7168667 [patent_doc_number] => 20050202098 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-09-15 [patent_title] => 'Disease therapy using dying or dead cells' [patent_app_type] => utility [patent_app_number] => 11/121048 [patent_app_country] => US [patent_app_date] => 2005-05-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 23835 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0202/20050202098.pdf [firstpage_image] =>[orig_patent_app_number] => 11121048 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/121048
Disease therapy using dying or dead cells May 3, 2005 Abandoned
Array ( [id] => 4832823 [patent_doc_number] => 20080131370 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-06-05 [patent_title] => 'Screening Method' [patent_app_type] => utility [patent_app_number] => 11/579104 [patent_app_country] => US [patent_app_date] => 2005-04-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 32267 [patent_no_of_claims] => 64 [patent_no_of_ind_claims] => 45 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0131/20080131370.pdf [firstpage_image] =>[orig_patent_app_number] => 11579104 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/579104
Screening Method Apr 25, 2005 Abandoned
Array ( [id] => 4948992 [patent_doc_number] => 20080305118 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-12-11 [patent_title] => 'Treatment Of Type 1 Diabetes With Inhibitors Of Macrophage Migration Inhibitory Factor' [patent_app_type] => utility [patent_app_number] => 10/594641 [patent_app_country] => US [patent_app_date] => 2005-03-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 15021 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0305/20080305118.pdf [firstpage_image] =>[orig_patent_app_number] => 10594641 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/594641
Treatment Of Type 1 Diabetes With Inhibitors Of Macrophage Migration Inhibitory Factor Mar 28, 2005 Abandoned
Array ( [id] => 7110606 [patent_doc_number] => 20050208061 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-09-22 [patent_title] => 'Treatment of autoimmune diseases by oral administration of autoantigens' [patent_app_type] => utility [patent_app_number] => 11/090321 [patent_app_country] => US [patent_app_date] => 2005-03-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 9320 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0208/20050208061.pdf [firstpage_image] =>[orig_patent_app_number] => 11090321 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/090321
Treatment of autoimmune diseases by oral administration of autoantigens Mar 24, 2005 Abandoned
Array ( [id] => 7050305 [patent_doc_number] => 20050186192 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-08-25 [patent_title] => 'Autologous T-cell vaccines materials and methods' [patent_app_type] => utility [patent_app_number] => 11/060848 [patent_app_country] => US [patent_app_date] => 2005-02-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 6915 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0186/20050186192.pdf [firstpage_image] =>[orig_patent_app_number] => 11060848 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/060848
Autologous T-cell vaccines materials and methods Feb 16, 2005 Abandoned
Array ( [id] => 4676187 [patent_doc_number] => 20080213817 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-04 [patent_title] => 'Enhancement of Th2-Dependent and Inflammatory Response' [patent_app_type] => utility [patent_app_number] => 10/590042 [patent_app_country] => US [patent_app_date] => 2005-02-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 30788 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0213/20080213817.pdf [firstpage_image] =>[orig_patent_app_number] => 10590042 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/590042
Enhancement of Th2-Dependent and Inflammatory Response Feb 16, 2005 Abandoned
11/052900 Treatment of diabetes Feb 8, 2005 Abandoned
Array ( [id] => 259870 [patent_doc_number] => 07572592 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-08-11 [patent_title] => 'Method for diagnosing multiple sclerosis' [patent_app_type] => utility [patent_app_number] => 11/047124 [patent_app_country] => US [patent_app_date] => 2005-01-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 9496 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 117 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/572/07572592.pdf [firstpage_image] =>[orig_patent_app_number] => 11047124 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/047124
Method for diagnosing multiple sclerosis Jan 30, 2005 Issued
Array ( [id] => 7252707 [patent_doc_number] => 20050142619 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-06-30 [patent_title] => 'Antibodies to mammalian langerhans cell antigen and their uses' [patent_app_type] => utility [patent_app_number] => 11/040774 [patent_app_country] => US [patent_app_date] => 2005-01-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22776 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0142/20050142619.pdf [firstpage_image] =>[orig_patent_app_number] => 11040774 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/040774
Antibodies to mammalian langerhans cell antigen and their uses Jan 20, 2005 Abandoned
Array ( [id] => 7111144 [patent_doc_number] => 20050208599 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-09-22 [patent_title] => 'Compositions and methods to select dendritic cells from a heterogeneous cell population' [patent_app_type] => utility [patent_app_number] => 11/039075 [patent_app_country] => US [patent_app_date] => 2005-01-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 9548 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0208/20050208599.pdf [firstpage_image] =>[orig_patent_app_number] => 11039075 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/039075
Compositions and methods to select dendritic cells from a heterogeneous cell population Jan 17, 2005 Abandoned
Array ( [id] => 5101759 [patent_doc_number] => 20070185021 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-08-09 [patent_title] => 'Diabetogenic epitopes' [patent_app_type] => utility [patent_app_number] => 10/597034 [patent_app_country] => US [patent_app_date] => 2005-01-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 21654 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0185/20070185021.pdf [firstpage_image] =>[orig_patent_app_number] => 10597034 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/597034
Diabetogenic epitopes Jan 9, 2005 Abandoned
Array ( [id] => 5034183 [patent_doc_number] => 20070098722 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-05-03 [patent_title] => 'Medicament comprising inhibitors of long pentraxin ptx3' [patent_app_type] => utility [patent_app_number] => 10/584292 [patent_app_country] => US [patent_app_date] => 2004-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1614 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0098/20070098722.pdf [firstpage_image] =>[orig_patent_app_number] => 10584292 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/584292
Medicament comprising inhibitors of long pentraxin ptx3 Dec 20, 2004 Abandoned
Array ( [id] => 4657052 [patent_doc_number] => 20080025913 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-01-31 [patent_title] => 'Novel Anti-Dc-Sign Antibodies' [patent_app_type] => utility [patent_app_number] => 10/583056 [patent_app_country] => US [patent_app_date] => 2004-12-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 10004 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0025/20080025913.pdf [firstpage_image] =>[orig_patent_app_number] => 10583056 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/583056
Novel Anti-Dc-Sign Antibodies Dec 14, 2004 Abandoned
Array ( [id] => 6982846 [patent_doc_number] => 20050152916 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-07-14 [patent_title] => 'Antigen presenting system and methods for activation of T-cells' [patent_app_type] => utility [patent_app_number] => 11/005750 [patent_app_country] => US [patent_app_date] => 2004-12-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 27 [patent_no_of_words] => 33073 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0152/20050152916.pdf [firstpage_image] =>[orig_patent_app_number] => 11005750 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/005750
Antigen presenting system and methods for activation of T-cells Dec 6, 2004 Abandoned
Array ( [id] => 5642640 [patent_doc_number] => 20060281095 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-12-14 [patent_title] => '44 human secreted proteins' [patent_app_type] => utility [patent_app_number] => 11/002754 [patent_app_country] => US [patent_app_date] => 2004-12-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 67513 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0281/20060281095.pdf [firstpage_image] =>[orig_patent_app_number] => 11002754 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/002754
44 human secreted proteins Dec 2, 2004 Abandoned
Array ( [id] => 5165221 [patent_doc_number] => 20070286805 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-12-13 [patent_title] => 'Methods of Validating Target for Modulating Insulin Action, Screening for Modulators of Insulin Action and Therapeutic Uses Thereof' [patent_app_type] => utility [patent_app_number] => 10/579125 [patent_app_country] => US [patent_app_date] => 2004-11-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 38 [patent_figures_cnt] => 38 [patent_no_of_words] => 41708 [patent_no_of_claims] => 58 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0286/20070286805.pdf [firstpage_image] =>[orig_patent_app_number] => 10579125 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/579125
Methods of Validating Target for Modulating Insulin Action, Screening for Modulators of Insulin Action and Therapeutic Uses Thereof Nov 14, 2004 Abandoned
Array ( [id] => 6938574 [patent_doc_number] => 20050112137 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-05-26 [patent_title] => 'Autoantigenic fragments, methods and assays' [patent_app_type] => utility [patent_app_number] => 10/977955 [patent_app_country] => US [patent_app_date] => 2004-10-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 20859 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0112/20050112137.pdf [firstpage_image] =>[orig_patent_app_number] => 10977955 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/977955
Autoantigenic fragments, methods and assays Oct 28, 2004 Abandoned
Menu